Minerva Surgical (NASDAQ:UTRS) Trading Down 8.9%

Minerva Surgical, Inc. (NASDAQ:UTRS)’s share price traded down 8.9% during mid-day trading on Wednesday . The stock traded as low as $0.51 and last traded at $0.51. 600 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 3,772 shares. The stock had previously closed at $0.56.

Minerva Surgical Stock Down 8.9 %

The firm’s 50-day moving average price is $0.62 and its 200-day moving average price is $1.48. The company has a market cap of $4.53 million, a price-to-earnings ratio of -0.06 and a beta of 0.67. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.88 and a quick ratio of 1.03.

Institutional Investors Weigh In On Minerva Surgical

Several large investors have recently made changes to their positions in the business. State Street Corp acquired a new stake in Minerva Surgical during the 2nd quarter valued at $36,000. Geode Capital Management LLC grew its holdings in Minerva Surgical by 284.7% during the 2nd quarter. Geode Capital Management LLC now owns 128,749 shares of the company’s stock valued at $33,000 after purchasing an additional 95,284 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in Minerva Surgical by 64.8% during the 1st quarter. Vanguard Group Inc. now owns 378,781 shares of the company’s stock valued at $1,705,000 after purchasing an additional 148,915 shares in the last quarter.

Minerva Surgical Company Profile

Minerva Surgical, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.